Publications (193) JUAN J VILCHEZ PADILLA publications

filter_list

2024

  1. AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action

    Science advances, Vol. 10, Núm. 41, pp. eadn6525

  2. Asymptomatic HyperCKemia in the Pediatric Population: A Prospective Study Utilizing Next-Generation Sequencing and Ancillary Tests

    Neurology, Vol. 104, Núm. 1

  3. Deletion of exons 45 to 55 in the DMD gene: from the therapeutic perspective to the in vitro model

    Skeletal muscle, Vol. 14, Núm. 1, pp. 21

  4. Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial

    Neurology, Vol. 102, Núm. 5

  5. Expanding the Clinical Spectrum of DRP2 -Associated Charcot-Marie-Tooth Disease

    Neurology, Vol. 102, Núm. 7

  6. ITPR3-associated neuropathy: Report of a further family with adult onset intermediate Charcot–Marie–Tooth disease

    European Journal of Neurology, Vol. 31, Núm. 12

  7. Insights into phenotypic variability caused by GARS1 pathogenic variants

    European Journal of Neurology, Vol. 31, Núm. 10

  8. Loss-of-function variants in JPH1 cause congenital myopathy with prominent facial and ocular involvement

    Journal of Medical Genetics

  9. Myosin ATPase inhibition fails to rescue the metabolically dysregulated proteome of nebulin-deficient muscle

    Journal of Physiology, Vol. 602, Núm. 20, pp. 5229-5245

  10. Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet Neurology, Vol. 23, Núm. 4, pp. 393-403